MXPA05013234A - Proteinas de capside de adenovirus quimericas. - Google Patents
Proteinas de capside de adenovirus quimericas.Info
- Publication number
- MXPA05013234A MXPA05013234A MXPA05013234A MXPA05013234A MXPA05013234A MX PA05013234 A MXPA05013234 A MX PA05013234A MX PA05013234 A MXPA05013234 A MX PA05013234A MX PA05013234 A MXPA05013234 A MX PA05013234A MX PA05013234 A MXPA05013234 A MX PA05013234A
- Authority
- MX
- Mexico
- Prior art keywords
- present
- adenovirus capsid
- capsid protein
- chimeric
- adenovirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
- C12N2810/405—Vectors comprising RGD peptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invencion se relaciona proteinas de capside de adenovirus quimerica que comprende una parte de o toda de una proteina de capside de adenovirus y una molecula de union de un sitio de union de la superficie celular sobre una celula presente en tejidos linfoides asociados con el intestino (GALT) de un mamifero, donde la proteina de la capside del adenovirus quimerica es capaz de unirse a la celula presente en los tejidos linfoides asociados con el intestino (GALT). En algunos ejemplos la proteina de la capside de adenovirus se localiza sobre la superficie de la capside del adenovirus La presente invencion proporciona capsides de adenovirus que comprenden una proteina de capside quimerica. La presente invencion tambien proporciona complejos que comprenden una proteina de capside de adenovirus quimerica unida a una celula en GALT. La presente invencion tambien proporciona sistemas y vectores de encapsulacion, en particulas vectores de adenovirus capaces de expresar una proteina de capside de adenovirus quimerica abarcada dentro dela invencion. La presente invencion tambien proporciona particulas virales, celulas anfitrionas y composiciones que comprenden esos vectores, en particular para usarse en vacunas, metodos para producir una respuesta inmune y metodos para la liberacion dirigida de proteinas heterologas, como antigenos, a celulas blanco.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47753903P | 2003-06-10 | 2003-06-10 | |
PCT/IB2004/002532 WO2004108755A2 (en) | 2003-06-10 | 2004-06-10 | Chimeric adenovirus capsid proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05013234A true MXPA05013234A (es) | 2006-03-09 |
Family
ID=33511850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05013234A MXPA05013234A (es) | 2003-06-10 | 2004-06-10 | Proteinas de capside de adenovirus quimericas. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050032045A1 (es) |
EP (1) | EP1631582A2 (es) |
JP (2) | JP5698426B2 (es) |
CA (1) | CA2527721C (es) |
MX (1) | MXPA05013234A (es) |
WO (1) | WO2004108755A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050032045A1 (en) * | 2003-06-10 | 2005-02-10 | Tikoo Suresh K. | Chimeric adenovirus capsid proteins |
WO2007050128A2 (en) * | 2005-05-31 | 2007-05-03 | Vectorlogics, Inc. | Shielded adenoviral vectors and methods of use |
JP5903045B2 (ja) * | 2009-07-31 | 2016-04-13 | パックスバックス, インコーポレイテッド | アデノウイルスに基づくベクター |
AU2014236207B2 (en) | 2013-03-14 | 2019-05-23 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
CN117384961A (zh) | 2016-02-23 | 2024-01-12 | 萨克生物研究学院 | 对病毒动力学影响最小的治疗性腺病毒中的外源基因表达 |
CA3013637A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
WO2018111767A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4152415A (en) * | 1978-08-18 | 1979-05-01 | Iowa State University Research Foundation, Inc. | Method of increasing the effectiveness of oral vaccination for swine dysentery |
US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
ZA907737B (en) * | 1989-09-29 | 1991-07-31 | Nisshin Oil Mills Ltd | Stable immunogen composition for oral administration |
US5352448A (en) * | 1992-07-20 | 1994-10-04 | Purdue Research Foundatioin | Oral administration of antigens |
US5543328A (en) * | 1993-08-13 | 1996-08-06 | Genetic Therapy, Inc. | Adenoviruses having modified fiber proteins |
US5820868A (en) * | 1993-12-09 | 1998-10-13 | Veterinary Infectious Disease Organization | Recombinant protein production in bovine adenovirus expression vector system |
US5559099A (en) * | 1994-09-08 | 1996-09-24 | Genvec, Inc. | Penton base protein and methods of using same |
US6060082A (en) * | 1997-04-18 | 2000-05-09 | Massachusetts Institute Of Technology | Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery |
DE69838644T2 (de) * | 1997-06-23 | 2009-05-14 | The University Of Saskatchewan | Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors |
CA2317941A1 (en) * | 1998-01-16 | 1999-07-22 | Genzyme Corporation | Adenoviral vectors with modified capsid proteins |
US5922576A (en) * | 1998-02-27 | 1999-07-13 | The John Hopkins University | Simplified system for generating recombinant adenoviruses |
US6492343B1 (en) * | 1998-04-15 | 2002-12-10 | University Of Saskatchewan | Porcine adenovirus type 3 genome |
EP1162246A1 (en) * | 1999-08-10 | 2001-12-12 | TDK Corporation | Coating composition for hard-coat formation on polycarbonate substrate, polycarbonate film with hard coat layer, and polycarbonate molding with hard coat layer |
CA2384827A1 (en) * | 1999-09-24 | 2001-03-29 | The Uab Research Foundation | Capsid-modified recombinant adenovirus and methods of use |
US6740525B2 (en) * | 2000-02-09 | 2004-05-25 | Genvec, Inc. | Adenoviral capsid containing chimeric protein IX |
JP2003534805A (ja) * | 2000-05-31 | 2003-11-25 | ユニバーシティ オブ サスカチュワン | 変化した親和性を有する改変ウシアデノウイルス |
MXPA03000373A (es) * | 2000-07-14 | 2003-10-15 | Univ Saskatchewan | Vectores de adenovirus que comprenden intrones. |
EP1432729B1 (en) * | 2001-07-02 | 2008-11-12 | Merrion Research III Limited | Peyers's patch and/or m-cell targeting ligands |
US20050032045A1 (en) * | 2003-06-10 | 2005-02-10 | Tikoo Suresh K. | Chimeric adenovirus capsid proteins |
-
2004
- 2004-06-10 US US10/866,013 patent/US20050032045A1/en not_active Abandoned
- 2004-06-10 WO PCT/IB2004/002532 patent/WO2004108755A2/en active Application Filing
- 2004-06-10 MX MXPA05013234A patent/MXPA05013234A/es unknown
- 2004-06-10 EP EP04744179A patent/EP1631582A2/en not_active Withdrawn
- 2004-06-10 CA CA2527721A patent/CA2527721C/en not_active Expired - Fee Related
- 2004-06-10 JP JP2006516610A patent/JP5698426B2/ja not_active Expired - Fee Related
-
2014
- 2014-12-02 JP JP2014244268A patent/JP2015051018A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2007535900A (ja) | 2007-12-13 |
WO2004108755A2 (en) | 2004-12-16 |
EP1631582A2 (en) | 2006-03-08 |
WO2004108755A3 (en) | 2005-05-19 |
CA2527721C (en) | 2016-05-10 |
JP5698426B2 (ja) | 2015-04-08 |
CA2527721A1 (en) | 2004-12-16 |
US20050032045A1 (en) | 2005-02-10 |
JP2015051018A (ja) | 2015-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009079564A3 (en) | Immunogenic compositions and methods of use thereof | |
HK1125051A1 (en) | Virus-like particles as vaccines for paramyxovirus | |
SI1888641T1 (sl) | Proteini ki vežejo serum albumin | |
HK1028981A1 (en) | Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins | |
WO2003068163A3 (en) | Optimization of gene sequences of chimeric virus-like particles for expression in insect cells | |
WO2004098535A3 (en) | Modified antibodies to prostate-specific membrane antigen and uses thereof | |
IL136634A0 (en) | Recombinant noda virus compositions and methods | |
MX2009010492A (es) | Elementos de vector de expresion recombinante (reves) para mejorar la expresion de proteinas recombinantes en celulas huesped. | |
WO2010105251A3 (en) | Non-integrating retroviral vector vaccines | |
EP2290091A3 (en) | Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions | |
WO2009055491A3 (en) | Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres | |
MXPA05013234A (es) | Proteinas de capside de adenovirus quimericas. | |
WO1999036545A3 (en) | Adenoviral vectors with modified capsid proteins | |
WO2002096939A3 (en) | Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization | |
WO2001087978A3 (en) | Human abc transporter and its use | |
WO2008082719A3 (en) | Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors | |
WO2001073028A3 (en) | A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor | |
EP1829552A3 (en) | Chlamydia PMP proteins, gene sequences and uses thereof | |
GB0401239D0 (en) | Adjuvant compositions | |
EP1515738A4 (en) | SCYTORIVINS AND CONJUGATES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOST CELLS, COMPOSITIONS AND RELATED ANTIBODIES, AND METHODS OF USING SCYTOVIRINS | |
WO2002016591A3 (en) | Human transporter family members and uses thereof | |
DE60142356D1 (de) | 18480 humane proteinkinasemoleküle und ihre verwendungen | |
WO2004091493A3 (en) | Improved heat shock protein-based vaccines and immunotherapies | |
WO2002051237A3 (en) | Helicobacter proteins, nucleic acids and uses thereof | |
WO2001079489A8 (en) | 39228, a human alcohol dehydrogenase and uses therefor |